Atnaujinkite slapukų nuostatas

Cancer Epigenetics: Risk Assessment, Diagnosis, Treatment, and Prognosis 2015 ed. [Kietas viršelis]

Edited by
  • Formatas: Hardback, 804 pages, aukštis x plotis: 254x178 mm, 31 Illustrations, color; 42 Illustrations, black and white; XVI, 804 p. 73 illus., 31 illus. in color., 1 Hardback
  • Serija: Methods in Molecular Biology 1238
  • Išleidimo metai: 25-Nov-2014
  • Leidėjas: Humana Press Inc.
  • ISBN-10: 1493918036
  • ISBN-13: 9781493918034
Kitos knygos pagal šią temą:
  • Formatas: Hardback, 804 pages, aukštis x plotis: 254x178 mm, 31 Illustrations, color; 42 Illustrations, black and white; XVI, 804 p. 73 illus., 31 illus. in color., 1 Hardback
  • Serija: Methods in Molecular Biology 1238
  • Išleidimo metai: 25-Nov-2014
  • Leidėjas: Humana Press Inc.
  • ISBN-10: 1493918036
  • ISBN-13: 9781493918034
Kitos knygos pagal šią temą:

This volume shares technologies that detect common epigenetic changes which are very important in the early detection, progression, and prognosis of cancer as well as the design of new therapeutic tools against cancer cells. Beginning with a bit of background on epigenetic mechanisms, Cancer Epigenetics: Risk Assessment, Diagnosis, Treatment, and Prognosis continues with cancer specific type epigenetic change, methods and technologies used for detecting epigenetic changes, factors that influence epigenetic changes in cancer, as well as a final section on future directions in the field. Written for the highly successful Methods in Molecular Biology series, chapters in this volume include the kind of detailed implementation advice that guarantees easily reproducible results.

Comprehensive and practical, Cancer Epigenetics: Risk Assessment, Diagnosis, Treatment, and Prognosis provides the most up-to-date knowledge of epigenetics and its implication in cancer prevention by risk assessment and screening and cancer control by treatment.

Preface v
Contributors xi
Part I Background: Epigenetic Mechanism
1 Cancer Epigenetics: An Introduction
3(24)
Rajnee Kanwal
Karishma Gupta
Sanjay Gupta
2 Community Resources and Technologies Developed Through the NIH Roadmap Epigenomics Program
27(24)
John S. Satterlee
Andrea Beckel-Mitchener
Kim McAllister
Dena C. Procaccini
Joni L. Rutter
Frederick L. Tyson
Lisa Helbling Chadwick
3 Epigenome-Wide Association Studies (EWAS): Past, Present, and Future
51(14)
James M. Flanagan
4 Epigenetic Biomarkers in Liver Cancer
65(14)
Krishna K. Banaudha
Mukesh Verma
Part II Cancer Specific Type Epigenetic Changes
5 Cancer Type-Specific Epigenetic Changes: Gastric Cancer
79(24)
Danielle Queiroz Calcagno
Marilia de Arruda Cardoso Smith
Rommel Rodriguez Burbano
6 Beyond the Island: Epigenetic Biomarkers of Colorectal and Prostate Cancer
103(22)
Andrea J. Savio
Bharati Bapat
7 Prostate Cancer Epigenome
125(16)
Swathi Chinaranagari
Pankaj Sharma
Nathan J. Bowen
Jaideep Chaudhary
8 CpG Island Hypermethylation as a Biomarker for the Early Detection of Lung Cancer
141(32)
Tujin Kim
Duk-Hwan Kim
9 Analysis of DNA Methylation in Pancreatic Cancer: An Update
173(10)
Christian Pilarsky
Robert Grutzmann
10 Epigenetics of Urothelial Carcinoma
183(34)
Wolfgang A. Schulz
Evangelia A. Koutsogiannouli
Gunter Niegisch
Michele J. Hoffmann
11 Epigenetics of Prostate Cancer
217(18)
Tawnya C. McKee
James V. Tricoli
12 Methylation Profile Landscape in Mesothelioma: Possible Implications in Early Detection, Disease Progression, and Therapeutic Options
235(16)
Xinbo Zhang
Naimei Tang
Arun K. Rishi
Harvey I. Pass
Anil Wali
Part III Methods and Technologies Used for Detecting Epigenetic Changes
13 Techniques to Access Histone Modifications and Variants in Cancer
251(22)
Monica Tyagi
Shafqat A. Khan
Saikat Bhattacharya
Divya Reddy
Ajit K. Sharma
Bharat Khade
Sanjay Gupta
14 Single Base Resolution Analysis of 5-Methylcytosine and 5-Hydroxymethylcytosine by RRBS and TAB-RRBS
273(16)
Maria A. Hahn
Arthur X. Li
Xiwei Wu
Gerd P. Pfeifer
15 Quantitative DNA Methylation Analysis for Epigenotyping of Colorectal Cancer
289(12)
Atsushi Kaneda
Koichi Yogi
16 Histone Modifications Associated with Cancer Cell Migration and Invasion
301(20)
Miki Hieda
Nariaki Matsuura
Hiroshi Kimura
Part IV Factors that Influence Epigenetic Changes in Cancer
17 Aberrant Epigenetic Modifications in Radiation-Resistant Head and Neck Cancers
321(12)
Hon-Yi Lin
Tim Hui-Ming Huang
Michael Wing-Yan Chan
18 Cancer-Associated Infectious Agents and Epigenetic Regulation
333(22)
Vidya Vedham
Mukesh Verma
19 Toxicoepigenomics and Cancer: Implications for Screening
355(14)
Mukesh Verma
20 Human Papilloma Virus (HPV) Modulation of the HNSCC Epigenome
369(12)
Josena K. Stephen
Maria J. Worsham
21 Epigenetic Regulation of HIV, AIDS, and AIDS-Related Malignancies
381(24)
Mukesh Verma
22 Epigenetics of Colorectal Cancer
405(20)
Wenji Yan
Mingzhou Guo
23 Epigenetics in Breast and Prostate Cancer
425(44)
Yanyuan Wu
Marianna Sarkissyan
Jaydutt V. Vadgama
Part V Future Directions: Risk Assessment, Diagnosis, Treatment, and Prognosis
24 Epigenetic Inhibitors
469(18)
Mukesh Verma
Hirendra Nath Banerjee
25 Use of Epigenetic Modulators as a Powerful Adjuvant for Breast Cancer Therapies
487(24)
Aurore Claude-Taupin
Michael Boyer-Guittaut
Regis Delage-Mourroux
Eric Hervouet
26 Epigenetic Approaches in Glioblastoma Multiforme and Their Implication in Screening and Diagnosis
511(12)
Gwyneth Hyman
Vinod Manglik
Jeffrey M. Rousch
Mukesh Verma
David Kinkebiel
Hirendra Nath Banerjee
27 Detection of Circulatory MicroRNAs in Prostate Cancer
523(16)
Anvesha Srivastava
Helle Goldberger
Zainab Afzal
Simeng Suy
Sean P. Collins
Deepak Kumar
28 Identification and Characterization of Small-Molecule Inhibitors of Lysine Acetyltransferases
539(10)
Daiqing Liao
29 Epigenetic Regulation in Biopsychosocial Pathways
549(20)
Kristin Litzelman
Mukesh Verma
30 Viral Epigenetics
569(28)
Barry I. Milavetz
Lata Balakrishnan
31 P53 Tumor Suppression Network in Cancer Epigenetics
597(10)
Alok Mishra
Daniel J. Brat
Mukesh Verma
32 Promoter Hypermethylation as a Biomarker in Prostate Adenocarcinoma
607(20)
Jong Y. Park
33 Sequencing the Cancer Methylome
627(26)
Austin Y. Shull
Satish K. Noonepalle
Eun-Joon Lee
Jeong-Hyeon Choi
Huidong Shi
34 Global DNA Methylation Profiling Technologies and the Ovarian Cancer Methylome
653(24)
Jessica Tang
Fang Fang
Dave F. Miller
Jay M. Pilrose
Daniela Matei
Tim Hui-Ming Huang
Kenneth P. Nephew
35 Recent Progress in the Discovery of Epigenetic Inhibitors for the Treatment of Cancer
677(12)
Sharad K. Verma
36 At the Crossroad Between Obesity and Gastric Cancer
689(20)
Jone Garai
Robert B. Uddo
Maura C. Mohler
Nicole Pelligrino
Richard Scribner
Melinda S. Sothern
Jovanny Zabaleta
37 Detection of Epigenetic Aberrations in the Development of Hepatocellular Carcinoma
709(24)
Yujing Zhang
38 Specific Type Epigenetic Changes in Cervical Cancers
733(18)
Shuping Zhao
39 Epigenetics in Head and Neck Cancer
751(20)
Syeda Marriam Bakhtiar
Amjad Ali
Debmalya Barh
40 Epigenetic Therapy for Colorectal Cancer
771(12)
Vivek Vaish
Tripti Khare
Mukesh Verma
Sharad Khare
41 Epigenetics of Gastric Cancer
783(18)
Mingzhou Guo
Wenji Yan
Index 801